I’ve sold out of IMCL at 38.50, making 20% in seven months on what was a large holding.
The FDA response on IMCL’s H&N sBLA is due today or tomorrow, so I may miss a pop on that news. If there is a pop. I also may miss a bigger pop on a buyout offer. C’est la vie.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”